# The Study of Drug 601 in Patients With Wet Age-related Macular Degeneration (wAMD)

> **NCT04468997** · PHASE1 · UNKNOWN · sponsor: **Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.** · enrollment: 67 (estimated)

## Conditions studied

- Wet Age-related Macular Degeneration

## Interventions

- **DRUG:** Drug 601
- **DRUG:** Drug 601
- **DRUG:** Drug 601
- **DRUG:** Drug 601
- **DRUG:** Drug 601
- **DRUG:** Drug 601

## Key facts

- **NCT ID:** NCT04468997
- **Lead sponsor:** Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-11-12
- **Primary completion:** 2021-03-15
- **Final completion:** 2021-09-15
- **Target enrollment:** 67 (ESTIMATED)
- **Last updated:** 2020-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04468997

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04468997, "The Study of Drug 601 in Patients With Wet Age-related Macular Degeneration (wAMD)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04468997. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*